Fibronostics

November is Diabetes Awareness Month – an important time to shine a light on the connections between diabetes and liver health! Diabetes is often linked to complications we may immediately think of, like heart disease and neuropathy, but there's another critical connection that's sometimes overlooked: liver health. Nonalcoholic fatty liver disease (NAFLD) affects approximately 25% of the world’s population and is particularly common among people with type 2 diabetes. When left unchecked, it can progress to more serious liver conditions, like nonalcoholic steatohepatitis (NASH), cirrhosis, and even liver cancer. Why is this important? The liver plays a key role in regulating blood sugar, managing cholesterol, and filtering toxins. When it’s not functioning optimally, managing diabetes becomes much more complex. Routine liver health assessments should be an essential part of diabetes care. During this month, let’s elevate the conversation around proactive liver health management, encourage regular liver screenings, and foster a more integrated approach to treating diabetes and related conditions. It’s time we bridge these health insights to promote better long-term outcomes for millions. #DiabetesAwarenessMonth #LiverHealth #NAFLD #NASH #LiverCare #Diabetes #LIVERFASt #LIVERSTAT

Happy Deepavali from Fibronostics! As we celebrate the Festival of Lights, we are reminded of the power of light to dispel darkness and hope to overcome challenges. May this Deepavali bring joy, health, and prosperity to you and your loved ones. At Fibronostics, we are grateful for the trust and support of our clients, partners, and community. Let’s continue working together to bring light to healthcare through innovation and dedication. Wishing everyone a bright, safe, and prosperous Deepavali! #Deepavali #FestivalOfLights #Fibronostics #HealthcareInnovation

Understanding MASH & MASLD The global rise of Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD)—formerly known as NAFLD—is alarming, with a subset of patients progressing to Metabolic dysfunction-Associated Steatohepatitis (MASH), a more severe stage of liver damage. Early detection and proactive management are crucial in reversing or slowing the progression of MASLD/MASH. At Fibronostics, we provide innovative, non-invasive diagnostic tools like LIVERFASt™ that help clinicians detect and monitor liver health with precision. By offering an accessible alternative to liver biopsy, LIVERFASt™ delivers critical insights into liver fibrosis, steatosis, and inflammation—empowering healthcare professionals to take timely action for their patients. Let’s work together to turn the tide on liver disease! #MASLD #MASH #LiverHealth #Fibronostics #LIVERFASt #LIVERSTAT #HealthcareInnovation #LiverCare

LIVERFASt™: A Reliable Tool for Long-Term Monitoring of MAFLD Patients A study data highlights that the LIVERFASt™ Fibrosis score, a non-invasive liver biopsy surrogate, correlates significantly with clinical endpoints such as ALT enzymatic activity improvement and BMI reduction. These correlations make LIVERFASt™ an effective tool for the long-term monitoring of patients with metabolic (dysfunction)-associated fatty liver disease (MAFLD). This blood-based biomarker test not only tracks liver fibrosis but also provides prognostic value for liver-related events and overall mortality. Patients achieving significant ALT reductions (≥50% from baseline) were more likely to experience liver fibrosis regression, offering hope for effective disease management. Read more about the findings in this poster presented at EASL: https://zurl.co/I8ym #MAFLD #LiverHealth #LIVERFASt #Fibrosis #ClinicalOutcomes #HealthcareInnovation #LongTermMonitoring

Liver disease can progress silently, but the good news is that early stages are reversible with timely intervention! The progression of Liver disease: 🔹 Healthy Liver: Less than 5% fatty cells.
 🔹 Fatty Liver/Inflammation: The liver is enlarged due to fat deposits or inflammation. At this stage, damage is reversible. 🔹 Fibrosis: Scar tissue begins to form, but the liver can still heal with intervention—reversible if caught early. 🔹 Cirrhosis: The liver hardens, leading to loss of function. This stage is often irreversible and can lead to severe health consequences. The first three stages are reversible if detected early. This is why early detection is critical. At Fibronostics, we’re committed to enabling healthcare professionals to identify liver disease before it’s too late with our non-invasive solutions. By providing comprehensive insights into liver health, patients and clinicians can be empowered to take timely action and potentially reverse liver damage. Don’t wait until it's too late. Early detection can save lives. #LiverHealth #LiverDisease #EarlyDetection #LIVERFASt #LIVERSTAT #HealthcareInnovation

It’s been an amazing couple of days, and we’re so grateful for the meaningful conversations and connections we’ve made. If you haven’t yet, there’s still time to stop by our booth and connect with us at Booth 808 at the Donald E. Stephens Convention Center to discover how LIVERFASt can revolutionize liver health management in your practice. Don’t miss out on your last chance to meet our CEO, Brock Smith, and our Liver Health Specialist, Ryan Schneider, ask questions, and explore the future of liver diagnostics with us. Let’s make the most of this final day! #PriMedMIdwest #CMEConference #LIVERFASt #Fibroconference #MeetOurTeam 

Only 1 day to go until Pri-Med Midwest 2024 kicks off! Our Fibronostics team is all set and excited to meet you at the Donald E. Stephens Convention Center from October 8−10. Don’t miss the chance to learn about LIVERFASt, our innovative liver health assessment solution that’s helping primary care providers make smarter, faster clinical decisions. Swing by our booth to meet the our team, Brock Smith and Ryan Schneider, and see how LIVERFASt can elevate liver care in your practice. We can't wait to connect! See you tomorrow! #PriMedMIdwest #CMEConference #LIVERFASt #Fibroconference #MeetOurTeam 

October is Liver Awareness Month! Liver health is something we often take for granted, but it plays a crucial role in our overall well-being. From processing nutrients to detoxifying the body, the liver is a powerhouse that keeps us functioning. Yet, liver diseases often go unnoticed until they become severe. This October, let’s take the opportunity to raise awareness, support those affected by liver conditions, and emphasize the importance of early detection and prevention. At Fibronostics, we are proud to contribute to liver health through our innovations, which helps in early detection and management of liver diseases. By leveraging technology, we aim to make liver health assessments more accessible and effective for both patients and healthcare providers. Here are a few steps we can all take to protect our liver health: ✅ Maintain a balanced diet ✅ Exercise regularly ✅ Limit alcohol consumption ✅ Get vaccinated against hepatitis ✅ Regularly monitor your liver function Let’s work together to make liver health a priority and ensure a healthier future for all. 💚 #LiverAwarenessMonth #LiverHealth #PreventLiverDisease #HealthcareInnovation #LIVERFASt

The Fibronostics team will be at the Pri-Med Midwest - Primary Care CME/CE Conference & Expo next week, from October 8−10, 2024, at the Donald E. Stephens Convention Center! We’re thrilled to showcase LIVERFASt, our cutting-edge non-invasive solution for assessing liver health. If you're attending, be sure to swing by our booth to learn how LIVERFASt is transforming the way we manage liver diseases. Come say hi, and let’s discuss how we can support your practice in delivering the best patient care. See you Chicago! #PriMedMIdwest #CMEConference #LIVERFASt #Fibroconference #MeetOurTeam

Did you know that your daily coffee habit could be doing more than just perking you up? According to research, drinking two cups of coffee a day can reduce the risk of cirrhosis by 44%, while four cups can lower it by an impressive 65%! As we celebrate this beloved beverage today, let’s raise a mug to coffee’s remarkable benefits and the power of prevention in maintaining liver health. Whether it’s your morning espresso or an afternoon latte, here’s to a cup of wellness! Happy International Coffee Day! #InternationalCoffeeDay #LiverHealth #CoffeeLovers #Wellness #FibroHealthTips